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Abstract
Background
Allograft vasculopathy (AV) remains a major obstacle to long-term allograft survival. While
the mouse aortic transplantation model has been proven as a useful tool for study of the
pathogenesis of AV, simultaneous transplantation of the aorta alongside the transplantation
of another organ may reveal more clinically relevant mechanisms that contribute to the pathogenesis of chronic allograft rejection. Therefore, we developed a combined abdominal
heart and aorta transplantation model in mice which benefits from reducing animal and drug
utilization, while providing an improved model to study the progressive nature of AV.

Methods
The middle of the infrarenal aorta of the recipient mouse was ligatured between the renal
artery and its bifurcation. Proximal and distal aortotomies were performed at this site above
and below the ligature, respectively, for the subsequent anastomoses of the donor aorta
and heart grafts to the recipient infrarenal aorta in an end-to-side fashion. The distal anastomotic site of the recipient infrarenal aorta was connected with the outlet of the donor aorta.
Uniquely, the proximal anastomotic site on the recipient infrarenal aorta was shared to connect with both the inlet of the donor aorta and the inflow tract to the donor heart. The outflow
tract from the donor heart was connected to the recipient inferior vena cava (IVC).

Results
The median times for harvesting the heart graft, aorta graft, recipient preparation and anastomosis were 11.5, 8.0, 9.0 and 40.5 min, respectively, resulting in a total median ischemic
time of 70 min. The surgery survival rate was more than 96% (29/30). Both the syngeneic
C57Bl/6 aorta and heart grafts survived more than 90 days in 29 C57Bl/6 recipients. Further,
Balb/c to C57Bl/6 allografts treated with anti-CD40L and CTLA4.Ig survived more than 90
days with a 100% (3/3) survival rate. (3/3).

Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
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stoma on the recipient abdominal aorta to reconstruct both the aorta graft entrance and
heart graft inflow tract. This allows for the study of allogeneic effects on both the aorta and
heart from the same animal in a single survival surgery.
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Introduction
Solid organ transplantation is one of the only viable interventions for patients with end-stage
organ failure. Beyond acute rejection, which is most prevalent in the first year post-transplantation and can be actively managed with adjustments in immunosuppressive regimen or
induction therapy [1, 2], the long term survival of transplanted hearts is impeded by graft failure, malignancy, cardiac allograft vasculopathy (CAV) and renal failure [1, 2]. Chronic allograft rejection remains one of the leading causes of graft failure one year post-transplantation
[1, 2].
It is well known that T cell-mediated immune responses play a central role in acute allograft
rejection [3]. Current immunosuppressive regimens targeting T cell activation and effector
cell function have led to dramatic reductions in acute rejection. However, chronic allograft
injury leading to graft failure and CAV remains a major obstacle to the long-term allograft survival [1, 2, 4]. Although the exact etiology remains unclear, multifactorial mechanisms including both immunological and non-immunological components contribute to the development
of chronic allograft rejection [5, 6]. In the heart, chronic allograft rejection presents as CAV,
and is characterized as an accelerated form of atherosclerosis which occurs in the arteries of
the transplanted heart [5, 6]. CAV is initiated by a combination of ischemia/reperfusion injury
and alloimmune injury which results in endothelial dysfunction [5, 6]. This leads to a progressive fibroproliferative disease with intimal smooth muscle cell proliferation leading to progressive vessel occlusion, thrombotic events and eventual graft failure [5, 6]. Allograft vasculopathy
(AV) can also occur in a number of solid organ transplant settings (i.e. lung, kidney, etc.) with
similar histopathological characteristics to CAV [7]. Despite current immunosuppressive regimens, CAV is reported in almost 50% of patients 10 years post transplantation [1, 2]. As such,
there is a growing need for the development of reliable animal models to decipher underlying
mechanism of CAV and further optimize and develop therapeutic strategies to address this
major health burden.
Heterotopic heart transplantation in mice has been considered the pre-eminent model to
study transplant immunology since it was introduced by Corry and Russell in 1973 [8]. Without immunosuppression, transplantation of a fully MHC-mismatched cardiac allograft
induces strong alloreactive T cell responses that mediate rapid graft rejection [9]. In this
regard, the heterotopic heart transplant model in mice recapitulates the pathological process of
acute allograft rejection. To study chronic allograft injury, immunosuppressive drugs have
used in this model to suppress the acute immune response. However, the majority of currently
used immunosuppressive drugs already target T cell activation to prevent acute transplant
rejection. Thus, the development of AV is likely a reflection of sub-acute immunological
events. Further, it has been suggested that these immunosuppressive agents may also contribute to the development of AV [10].
The aortic transplant model in mice has been used to study some components of the immunological and/or molecular mechanisms of AV. However, fully MHC-mismatched aortic allografts demonstrate long-term survival even in absence of immunosuppression [11]. On one
hand, this allows for the study of mechanisms that contribute to AV in the absence of a strict
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influence from acute rejection, as acute rejection episodes have long been considered as a risk
factor for the future development of AV [12]. However, as aortic allografts do not undergo
acute rejection, it remains controversial whether the vascular changes observed in aortic allografts accurately represent those that occur in solid organ transplants [13].
To address some of these issues, investigators have developed combined heart and aorta/
carotid artery transplantation models in mice to investigate the potential impact of acute rejection on CAV [13, 14]. As expected, compared with isolated carotid allografts, a significantly
more intimal hyperplasia of carotid allografts was noted in aorta transplanted in combination
with a heart graft, indicating that CAV is promoted by acute parenchymal rejection of the
heart [14]. This observation has further highlighted the need for transplantation of a parenchymal organ in combination with an aortic graft to more accurately model the events which contribute to the pathogenesis of CAV in human heart allografts. Despite impressive results made
utilizing their models, the transplantation of heart and aorta/carotid graft into two different
operative sites (abdominal and cervical respectively) causes increased operative traumas and
prolonged operative times, limiting its widespread use. In order to simplify the surgical protocol and remove the need for multiple survival surgeries (resulting in reductions in graft ischemia and overall operative times), we developed a new technique to transplant heart and aorta
graft in a single site within the abdomen. Further, transplantation of the aorta and heart in a
single surgery reduces donor animal utilization. The aim of our study was therefore to evaluate
a new microsurgical technique of simultaneous heterotopic abdominal heart and aorta transplantation in mice, as well as to assess the feasibility of sharing a common anastomotic stoma
on the recipient infrarenal aorta to reconstruct both the aorta-graft entrance and heart-graft
inflow tract.
Our results demonstrate that this new surgical protocol is reliable, reproducible and
improves upon existing techniques. Further studies using this model will provide insight into
the clinical process of chronic allograft rejection and a useful tool for assessing the novel
immunosuppressive strategies for its prevention. In addition, to our knowledge, this is the first
demonstration of a novel microsurgical technique in which an anastomotic stoma on the
recipient infrarenal aorta can be connected with two individual vessels, providing a new pathway of revascularization for multi-organ transplantation.

Materials and methods
Animals
Adult female Balb/c mice 6–10 weeks of age (20-25g body weight) and male C57Bl/6 mice,
6–10 weeks of age (20-25g body weight) were purchased from Jackson Laboratory (Bar Harbor, MD, USA). Animals were housed under standard conditions subjected to regular 12-hour
light-dark cycles. Water and chow were supplied ad libitum. Animal experiments were conducted in accordance with an approved Washington University School of Medicine (WUSM)
Institutional Animal Care and Use Committee (IACUC) protocol (#20190173). Anesthesia
was induced by a mixture of ketamine (80–100 mg/kg)/xylazine HCl (8–12 mg/kg), intraperitoneally (i.p.) and maintained with 1–2% isoflurane gas, as required.

Donor operation
A longitudinal laparotomy was made, and abdominal contents were reflected to the left side to
expose the inferior vena cava (IVC). Approximately 1.0 mL of cold saline containing heparin
(100 U/mL) was injected into the IVC. After 1 minute for systemic heparinization, an aortotomy of the abdominal aorta was made to decompress the blood circulatory system. Subsequently, a bilateral thoracotomy was performed through the ribs along both sides of the
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thoracic spine, then the anterior chest wall was levered up cranially. The IVC around diaphragmatic hiatus was clamped with a hemostat, above that, the IVC was cannulated and then 0.5
mL of cold heparin (100 U/mL) is again infused into the right atrium. The thymus was resected
to expose the aortic arch and pulmonary artery. The ascending aorta was transected proximal
to the innominate artery. The pulmonary artery was transected proximal to its bifurcation.
The IVC and the right superior vena cava (SVC) were proximally ligated with 7–0 sutures. A
5–0 ligature was placed underneath the IVC and the right SVC and around the heart to ligate
all other vessels en bloc including the pulmonary veins and the left SVC as distally as possible.
The IVC, the right SVC and the remaining connective tissues were all dissected distally in
order. The donor heart was then gently detached from the thorax and stored in ice-cold saline.
In the following steps, the donor thoracic descending aorta would be harvested as described by
Cho et al [15]. Lungs were resected, then the diaphragm was divided as close to the aorta as
possible to expose descending aorta. The descending aorta was further flushed by cold heparin
(100 U/mL) solution from the aorta bellow the diaphragm. The parietal pleura in front of the
descending aorta were divided. Intercostal arteries were carefully divided from the segment of
the descending aorta between the left subclavian artery proximally and the diaphragmatic hiatus distally. The thoracic descending aorta was harvested and stored in ice-cold saline.
Although the thoracic aorta can be divided into three segments for individual transplantation,
it is preferable to use the proximal section, as it is most compatible in diameter with ascending
aorta of the donor heart, and therefore facilitates the subsequent anastomosis.

Recipient operation
A midline laparotomy was made from the pubis to the xiphoid, then a micro-retractor was
placed to expose the abdominal cavity. The intestines were gently retracted right outside the
abdomen and covered with moistened gauze and kept moist throughout the procedure with
saline. Using two cotton swabs, the abdominal aorta and the IVC below the renal vessels and
above its bifurcation were exposed and dissected gently from the surrounding tissues. Of note,
a complete isolation of infrarenal aorta from IVC was unnecessary for performing subsequent
end-to-side anastomosis. One or two groups of the lumber arteries and veins underneath the
abdominal aorta and IVC were ligated with 9–0 silk sutures. To interrupt the blood flow in
both the aorta and the IVC, a 5–0 silk was single-tied at the proximal side of its bifurcation to
allow it to be untied easily after anastomosis, and then a micro clamp was placed just at below
the renal vessels. Next, the middle of the sequestered aorta was sutured with a 9–0 nylon suture
(Fig 1A and 1B). Thus, the aorta was partitioned into proximal and distal anastomotic areas
without transection. The proximal and distal aortotomies were performed above and below
the ligature respectively, for the subsequent anastomoses of the aorta- graft into the recipient
in an end-to-side fashion (Fig 2A). We preferred to make the aortotomy by a simple and reliable technique described by Mao et al. [16]. Briefly, the tip of a 4 mm (3/8) needle was longitudinally passed in and slightly out of the anterior wall of the recipient aorta and kept in position
by a needle holder. By gently lifting the needle upwardly, the piece of the anterior wall of the
aorta above the needle could be easily excised by cutting underneath the needle with fine scissors, so that an approximate 1 mm elliptical opening with the trim-edge was made. In the
same way, a venotomy in parallel with proximal aortotomy was made for the subsequent construction of heart-graft outflow tract. The openings of the aorta and the IVC were flushed with
saline to remove the blood.
The aorta graft was placed on the left side of the recipient abdomen, and then covered with
gauzes moistened with icy cold saline. First, using 11–0 nylon surgical suture, the aorta-graft
exit was constructed in the distal anastomotic site of the recipient infrarenal aorta in an end-
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Fig 1. Diagrammatic (A) and photographic (B) representation of the middle of the recipient’s infrarenal aorta between renal artery and its bifurcation, which was
ligatured with a 9–0 nylon suture.
https://doi.org/10.1371/journal.pone.0230649.g001

to-side fashion. The posterior and the anterior walls of the anastomosis were completed inside
and outside the vessels with 4–5 continuous running sutures, respectively. The aorta-graft
entrance and heart-graft inflow tract were then constructed by sharing to connect the proximal
anastomotic site of the recipient infrarenal aorta. Briefly, the left side of the anastomotic site of
the recipient infrarenal aorta was anastomosed to the posterior wall of the donor aorta-graft
inside vessel (Fig 2B). In the following step, the donor heart graft was placed on the left side of
the recipient abdomen with the remnant of the ascending aorta underneath the pulmonary
artery and perpendicular to the clamped vessels, and then covered with gauze moistened with
ice-cold saline. The anterior wall of the aorta-graft was anastomosed to the posterior wall of
the ascending aorta of the heart-graft inside vessel (Fig 3A and 3B). The anterior wall of the
ascending aorta of the donor heart was then anastomosed to the right side of the anastomotic
site of the recipient infrarenal aorta outside vessel (Fig 4A and 4B). The last step in the procedure was to construct the heart-graft outflow tract, similarly, by an end-to-side anastomosis
between the donor pulmonary artery and the recipient IVC with continuous running sutures
of the posterior wall inside vessel and the anterior wall outside vessel (Fig 5A).
After completion of anastomoses, the distal ligature was untied first, followed by removal of
the proximal clamp. The anastomotic sites were gently pressed by two cotton swabs for several
seconds, to minimize/stop bleeding. Optionally, small pieces of hemostatic agent, spongostan,
can be placed around the anastomotic sites to prevent anastomotic bleeding. Normally, the
aorta- and heart- graft immediately fills with blood and consequently becomes bright red in
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Fig 2. (A) Diagrammatic representation of the proximal and the distal aortotomies on the recipient’s infrarenal aorta were performed above and below the ligature,
respectively, for the subsequent anastomoses of the donor’s aorta graft into the recipient in an end-to-side fashion. (B) Diagrammatic representation of the left side of
the anastomotic site of the recipient’s infrarenal aorta, which was anastomosed to the posterior wall of the donor’s aorta graft within the vessel.
https://doi.org/10.1371/journal.pone.0230649.g002

Fig 3. Diagrammatic (A) and photographic (B) representation of the anterior wall of the aorta graft, which was anastomosed to the posterior wall of the ascending aorta of
the heart graft within the vessel.
https://doi.org/10.1371/journal.pone.0230649.g003
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Fig 4. Diagrammatic (A) and photographic (B) representation of the anterior wall of the ascending aorta of the heart graft, which was anastomosed to the right side of the
anastomotic site of the recipient’s infrarenal aorta.
https://doi.org/10.1371/journal.pone.0230649.g004

color. Prominent pulsations of the aorta-graft were visible and after a short episode of fibrillation, sinus rhythm resumed in the heart-graft (Fig 5B). After ensuring there was no further
bleeding, the abdominal incision was closed with 4–0 suture by continuous running stitches.
Immunosuppression. For a subset of additional transplants, the long-term viability of
this combined aorta and heart transplant model were tested in syngraft (C57Bl/6 to C57Bl/6)
(n = 3) and allograft (Balb/c to C57Bl/6) models (n = 3), with the administration of 250 μg of
InVivoMab anti-mouse CD40L (CD154; clone MR-1; Bio X Cell, West Lebanon, NH) on the
day of transplantation, and 200 μg of InVivoMab recombinant CTLA-4-Ig (hum/hum; Bio X
Cell) on day 2 post-transplantation [17, 18].
Histology and imaging. Four representative sections from each aortic and heart graft
were stained with hematoxylin and eosin (H&E; Leica Biosystems, Buffalo Grove, IL) or
Movat’s pentachrome (Newcomer Supply, Middleton, WI) and digital images were captured
using an Olympus BX61 microscope (Center Valley, PA).

Results
A total of 30 combined heterotopic abdominal heart and aorta syngrafts were performed using
this technique in C57Bl/6 mice. A median time of 11.5 min (10–14 min range) and 8.0 min (7–
10 min range) was required for harvesting of the donor heart and aorta grafts, respectively.
Preparation of the transplant recipient required a median time of 9.0 min (8–11 min range),
and anastomoses of the donor organs required a median time of 40.5 min (38–44 min range).
There was a median total ischemic time of 70 min (65–74 min range) (Fig 6). The surgery
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Fig 5. Diagrammatic (A) and photographic (B) representation of the outflow tract (pulmonary artery) of the donor’s heart graft, which was connected to the recipient’s
inferior vena cava (IVC).
https://doi.org/10.1371/journal.pone.0230649.g005

survival rate of syngrafts was greater than 96% (29/30). One mouse died due to anastomotic
hemorrhage on the same day as transplantation. The remaining 29 of 30 syngrafts survived
greater than 90 days with maintained transplanted heart function (as assessed by palpation).
To validate this surgical method, we subsequently performed allografts using Balb/c donor
aorta and hearts transplanted into C57Bl/6 recipients (n = 3) in the presence of double co-stimulatory blockade [17, 18] or syngrafts using C57Bl/6 donor aorta and hearts transplanted into
C57Bl/6 recipients (n = 3) as a control. For this group, 3/3 allografts and 3/3 syngrafts survived
for more than 90 days, with maintained transplanted heart function (as assessed by palpation).
Histological examination of aorta (Fig 7A) or cardiac (Fig 7B) grafts revealed long-term survival with a mild immune response, due to the strong immunosuppressive effect of double costimulatory blockade.

Discussion
AV is resistant to current immunosuppressive therapies and a major obstacle to long-term survival in solid organ transplantation. Although, there are controversies concerning the relative
contribution of acute transplant rejection to the subsequent development of AV, current evidence increasingly suggests that acute rejection is a strong risk factor for the late development
of AV [1, 2]. Indeed, clinical reduction in acute rejections has significantly decreased the incidence of chronic rejection graft failure [1, 2, 19].
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Fig 6. Median time for donor heart harvest (red), donor aorta harvest (blue), transplant recipient preparation
(green), total anastomosis time for the combined transplant procedure (pink) and total ischemic time (orange).
Data are represented as median time (in minutes) ± the range in time for all procedures. n = 30 transplants.
https://doi.org/10.1371/journal.pone.0230649.g006

The aortic transplant model in mice is a useful tool for studying AV, based on the formation
of consistent lesions which can be easily quantified [20]. However, unlike solid organ allografts, isolated aortic allografts can achieve long-term acceptance in the absence of immunosuppressive interventions, sparing them from the influence of acute rejection. Therefore, this
model lacks the contribution of cellular and soluble factors present in acute rejection that may
augment the pathogenesis and evolution of CAV. In contrast, the strategy of combining aortic
transplantation with solid organ transplantation includes the influence of systemic factors
related to acute allograft rejection on the development of CAV, thus providing a model that
may more accurately represent chronic allograft rejection. Indeed, Soleimani et al. demonstrated a marked increase in neointimal area in C57Bl/10 carotid grafts co-transplanted with
Balb/c cardiac allografts into a C3H recipient mouse, compared to C57Bl/10 carotid grafts into
C3H recipients [14]. This observation confirmed that the acute parenchymal rejection is an
important contributor to CAV, and further emphasizes that a combined model may serve as a
more clinically relevant model to investigate the mechanisms involved in the development of
AV.
Researchers have developed the combined aorta/carotid and heart transplantation models
in mice, in which the aorta/carotid and heart are transplanted into two different surgical sites
(abdomen and cervical region, respectively). A likely rationale for the use of an additional surgical site is that there is insufficient space along the recipient abdominal aorta between the
renal artery and its bifurcation to make three aortotomies for connecting aorta-graft entrance
and exit as well as heart-graft inflow tract. Thus, a cervical operation has to be performed to
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Fig 7. Representative micrographs of the aortic (A) and cardiac (B) grafts 90+ days post-transplantation treated with anti-CD40L and CTLA4.Ig
stained with hematoxylin & eosin. Scale bars = 100 μm for (A); 500 μm for (B).
https://doi.org/10.1371/journal.pone.0230649.g007
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accommodate another graft. However, two surgical sites of operations are associated with
additional surgical procedures and prolonged anaesthesia, frequently resulting in increased
surgical complications and mortality. To avoid the unnecessary surgical traumas and shorten
the ischemia and overall operative times, we developed a simplified model, in which two individual grafts can be accommodated in a single surgical site of abdomen with a high success
rate.
Several arterial transplantation models have been well-established in mice [20–24]. Both
aortic and carotid grafts are most commonly used for study of CAV [21, 22]. Compared to
carotid segments with similar length, aortic grafts are larger in size, and therefore can provide
more tissue for subsequent histological and biochemical analysis. In our experience, a wholelength of thoracic ascending aorta from a single donor is long enough to be divided and transplanted into three to four individual recipients (unpublished observation). Therefore, use of
an aortic graft rather than a carotid graft is superior in such models.
In mice, aortic grafts can be anastomosed to the recipient infrarenal aorta by either an endto-end [20] or an end-to-side [11] anastomosis pattern. Due to the obvious disparity in size
between the thoracic and abdominal segments of the aorta, the end-to-end pattern is technically more difficult, with a higher incidence of anastomotic complications (up to 20% of
thrombotic complications reported) [20]. In contrast, the end-to-side pattern is technically
more facile, leading to a greater than 98% success rate [11]. In addition, a mild dissection of
the infrarenal aorta from IVC is sufficient to perform an end-to-side anastomosis. Thus, the
donor operation is simplified by obviating the dissection of abdominal vessels, which are very
easily injured. Of note, a potential limitation of this pattern is that a curved loop of aortic graft
may alter blood flow patterns and produce unexpected and unreliable experimental results. To
address this issue, after completion of the procedure of end-to-side anastomosis, Sun et al. [11]
tried to convert an end-to-side to a quasi end-to-end anastomosis by transection of the native
infrarenal aorta between the anastomotic sites of aortic allograft entrance and exit. However,
this technique appeared to increase the likelihood of kinking at the anastomotic sites [25].
Importantly, data showed a loop and an interposition of aortic allograft made by end-to-side
and end-to-end pattern respectively, yielded similar experimental results [25]. Therefore, on
the basis of merit, we combined the end-to-side anastomosis pattern of aortic transplant without transection of native infrarenal aorta described by Cho et al. [15] for our study.
We used the abdominal site to implant both heart and aortic allografts, because the abdominal infrarenal aorta is much larger in size and longer than the carotid artery. Although the
infrarenal aorta was divided from the IVC, a complete separation of these vessels from each
other was unnecessary. Instead, a mild dissection of the abdominal vessels was easily performed and adequate to facilitate an end-to-side anastomosis. In order to transplant both
heart and aorta grafts, three anastomotic stomas in the recipient infrarenal aorta were needed
for reconstruction of aorta-graft entrance and exit as well as heart-graft inflow tract. However,
we discovered that two adequate aortotomies, at a maximum, can be made in recipient infrarenal aorta for anastomosis, despite attempting to replace the distal clamp with a ligature of 5–0
silk to maximize the usage of the infrarenal aorta. To address this issue, we adopted the proximal anastomotic stoma on the recipient infrarenal aorta to connect both aorta-graft entrance
and heart-graft inflow tract, increasing the available space along the recipient infrarenal aorta.
Results obtained from our study demonstrated this novel microsurgical technique can be easily
performed with a high success rate, without thrombotic occlusion or stenosis observed in
heart and aortic allografts. This novel technique also provides a new pathway in revascularization for multi-organ transplantation within a limited space.
Su et al. [26] argued that an entire everting suture technique was able to decrease the anastomotic complications. However, in our laboratory, we favored the parachute technique to
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suture the vessel posterior walls inside the vessels (inverting suture) and anterior walls outsider
the vessels (everting suture). In this way, grafts did not need to be re-positioned to the opposite
side, and therefore the possibility of increased surgical complexities and warm ischemia times
was further limited. In our previous experience with this method, a success rate of greater than
90% could be reliably achieved by a skilled microsurgeon for heterotopic heart transplantation
in mice. In our current model, we adopted the same suture technique and achieved a similarly
high success rate. In addition, using a technique described by Mao et al. to create the aortotomy and the venotomy [16], an elliptical anastomotic stoma can be easily made with a trimedge, which may facilitate the vascular anastomosis. Nevertheless, proficiency in microsurgical
techniques is required to enable researchers to achieve reliable and reproducible results with
this model.

Conclusions
In conclusion, our study presents a simple and reliable technique for combined heterotopic
abdominal heart and aorta transplantation in mice, which can be achieved by sharing a common anastomotic stoma on the recipient infrarenal aorta with two individual graft vessels. Further studies using this model should provide additional insight into the mechanism of CAV
and reveal correlation between the acute rejection and the subsequent development of CAV.
In addition, the novel technique applied in this model provides a new pathway for revascularization and increases availability of methodological options for the development of experimental animal models.
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